Phosphatidylserine OEM Artwork and Label Approval: A Workflow for US and EU Supplement Brands

A phosphatidylserine product can clear formulation, testing and stability and still miss its launch because the label was wrong: a claim the market does not allow, a Supplement Facts panel with the wrong basis, a missing language variant, or a barcode that will not scan. In OEM production these failures cost twice — reprint cost, and production slots already booked against the artwork release.

The fix is procedural: treat the label as a controlled document with two approval gates before design, a defined artwork cycle, and change control that survives the first market expansion. This article lays out that workflow from the brand side, with the OEM-side handoffs most guides leave out.

Who Owns the Label in OEM Production

In contract manufacturing, the brand almost always owns the artwork and the claims; the contract manufacturer owns print execution, label application accuracy and label-to-batch reconciliation. The split matters because each side fails differently: the OEM cannot know your marketing intent, and you cannot rely on a print operator to catch a substantiation problem. Write the ownership into the manufacturing or artwork agreement:

• Brand provides: final artwork files, claims matrix with substantiation dossier, regulatory review sign-off, dielines where brand-owned, and named approval authorities.
• OEM provides: dieline templates for their labeler and print process, panel placement constraints, proof submission, label reconciliation at line clearance, and a commitment not to amend artwork without written brand approval.
• Shared: the version number on every proof, printed file and change control record.

Brands that skip this section of the agreement discover that "the printer fixed a typo" — and with it changed a word in the claim.

Gate One: The Claims Matrix and Ingredient Specification Lock

Approve claims before design, not after. Build a claims matrix with four columns: exact wording as it will appear, market (US, EU, member states), legal basis, and status. For phosphatidylserine this gate has market-specific teeth:

• US: structure/function claims require substantiation and the section 403(r)(6) disclaimer, plus the "not evaluated by the FDA" statement. Claims must stay inside the dietary supplement framework — no disease claims on any panel, including the website the label's QR code points to.
• EU: nutrition and health claims are only permitted if they appear in the EU register of authorised claims. Many phosphatidylserine claims common in US marketing have no authorised EU counterpart; using them on an EU label is non-compliant regardless of substantiation quality, and member states can add restrictions for supplements.
• Both markets: claim wording interacts with product positioning (food supplement versus medical food), which changes the entire labelling regime.

Lock the ingredient specification at the same gate. A named dose per serving only survives if the OEM's blend and assay basis delivers it with margin — the label claim ties back to the batch calculation basis agreed in the specification.

Gate Two: Market-Specific Mandatory Particulars

Before artwork starts, compile the mandatory particulars checklist per market and hand it to the designer as a content brief, not a review task:

• US: statement of identity, net quantity, Supplement Facts panel in the prescribed format, other ingredients list, name and place of business of the manufacturer/distributor, and the structure/function disclaimer where claims are made. Placement and formatting rules apply to the panel.
• EU: name of the food (indicating the supplement nature), the list of ingredients with allergen emphasis, quantity of the characterising ingredient (PS per daily portion), nutrition declaration, net quantity, date of minimum durability with storage and conditions of use, name and EU address of the operator, country of origin where required, plus member-state additions such as mandated supplement warning statements.
• Multilingual versions: every market's mandatory particulars must appear in the required languages — decide the language matrix before design, since it drives label count and panel space.

A brand selling the same formula in the US and two EU markets is approving three controlled documents that must stay in revision lockstep, not one label.

The Artwork Cycle: Brief, Draft, Regulatory Review, Sign-off

Run the cycle as four named steps with one approval authority each:

1. Brief: designer receives the claims matrix, mandatory-particulars checklist, the OEM's dieline, brand assets and GS1 barcode numbers. The brief states which elements are fixed regulatory text that may not be restyled.
2. Draft: first artwork at dieline scale, reviewed against the checklist line by line — mandatory particulars present, claim wording matching the matrix exactly, dose statements matching the specification, allergen emphasis correct.
3. Regulatory review: a named regulatory owner signs that the artwork matches the approved matrix for every market on the file. This signature is the audit artefact.
4. Sign-off: approval recorded with a version number (e.g., ART-v1.0), date and approver, shown on the proof and in the OEM's controlled file.

Two review habits catch most errors: read the regulatory text aloud from the artwork (the eye autocorrects; the ear does not), and verify every number on the label against the specification — serving size, per-dose PS content, ingredient order and net weight.

Printer Proofs, Dielines and Line Clearance

The OEM's print stage introduces its own failure modes. Check the physical proof, not the PDF: colour fidelity, text legibility at final size (small Supplement Facts panels and long EU ingredient lists suffer first), barcode scan quality, die-cut registration, and substrate behaviour on the final jar, drum or pouch.

At production, line clearance is the last control: the OEM verifies that labels loaded on the line match the approved version for that batch, that old-version labels are physically removed, and that the reconciliation count is recorded. Ask for the label reconciliation figure in the batch record — an uncounted label is a recall-scenario liability, since a misapplied old label puts the wrong claims in a market.

Version Control and the Artwork Approval Log

Keep a single artwork approval log with one row per version: version number, markets covered, change description, approver, approval date, and the archive location of the released file and proof. The OEM holds the same version as the controlled print file; archive every superseded version, marked void. When a regulator or retailer asks which label version was on the batch you shipped in March, the log plus the batch record answers in minutes — and the answer must match.

Change Control After Launch

Post-launch, treat every artwork touch as change control with an impact assessment: does the change touch a claim (re-run the matrix), a mandatory particular (re-run the checklist for every market on the file), the barcode, or cosmetics only? Revisions trigger a new version number, re-approval, a depletion plan for old label stock, and updated OEM line clearance records.

Watch the natural drift points: a supplier change that alters allergen status or the excipient list, a new market bolted onto an existing file, a serving size change that shifts the panel, and marketing requests to "refresh" wording. Each is a controlled change — the ones that hurt are the ones handled as email favours.

Preguntas frecuentes

Q: Who is responsible for label compliance in OEM supplement production?

A: Typically the brand owns artwork, claims and regulatory sign-off; the contract manufacturer owns print execution, label application and reconciliation. Allocate both sides explicitly in the manufacturing or artwork agreement.

Q: What must be approved before supplement artwork goes to print?

A: Two gates: a claims matrix (exact wording, market, legal basis, status) and a market-specific mandatory particulars checklist. Design starts only after both are signed, and regulatory review then verifies the artwork against them line by line.

Q: What mandatory information must appear on an EU food supplement label?

A: At minimum: the supplement name, ingredient list with allergen emphasis, quantity of the characterising ingredient per daily portion, nutrition declaration, net quantity, minimum durability date with storage and use conditions, and the operator's name and EU address — plus member-state additions — in the required languages.

Q: How should artwork be version controlled with a contract manufacturer?

A: A version number on every proof, released file and printed label run; a shared approval log recording change description, approver and date per version; superseded versions archived as void; and line clearance confirming the printed labels match the batch's approved version.

Q: When does a label change require change control?

A: Any post-release revision — even cosmetic. The impact assessment determines depth: claim changes re-run the substantiation matrix, particular changes re-run the market checklist, and all revisions get a new version, re-approval, and a depletion plan for old label stock.

Conclusión

Label failures in outsourced PS production are process failures: claims approved after design, mandatory particulars discovered at proof, versions drifting between brand and printer. The workflow that prevents them is short — a claims matrix and particulars checklist before design, a four-step artwork cycle with named approvals, physical proof review, and version control the OEM's line clearance actually uses. The approval log you start with your first label is the artefact that makes your fiftieth audit boring.

Fuentes

• U.S. Food and Drug Administration (FDA) — Food Labeling Guide and dietary supplement labeling requirements (21 CFR Part 101): https://www.fda.gov/food/food-labeling-nutrition/food-labeling-guide-nutrition-labeling-information
• U.S. Food and Drug Administration (FDA) — Dietary Supplements: labeling and structure/function claims: https://www.fda.gov/food/dietary-supplements
• European Commission — Regulation (EU) No 1169/2011 on food information to consumers: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32011R1169
• European Commission — EU Register of nutrition and health claims (Regulation (EC) No 1924/2006): https://ec.europa.eu/food/safety/labelling_nutrition/claims/register/
• GS1 — General Specifications for barcodes: https://www.gs1.org/standards/barcodes

Próximos pasos recomendados

• Revisa el Phosphatidylserine página del producto.
• Comparar Soy PS y Sunflower PS.
• Verificar prueba de fabricación y Calidad e I+D.